Moreover, our results show that there is an association between low HAS2 immunostaining intensity and IDH1 –mutation, which is a known positive prognostic factor in diffusely infiltrating astrocytomas. The gene discussed is HAS2; the disease is astrocytoma (excluding glioblastoma).